Related Experiment Videos
Oxygen radical-mediated DNA damage by redox-active Cr(III) complexes.
K D Sugden1, R D Geer, S J Rogers
1Department of Chemistry and Biochemistry, Montana State University, Bozeman 59717.
Biochemistry
|November 24, 1992
Summary
Mutagenic chromium(III) complexes induce DNA damage through a Fenton-like reaction involving oxygen radicals. Ligand choice significantly influences chromium
Area of Science:
- Environmental toxicology
- Biochemistry
- Molecular biology
Background:
- Chromium(III) is the biologically active form of chromium, but its mechanism of DNA damage remains unclear.
- Understanding chromium-induced mutagenesis is crucial for assessing its health risks.
Purpose of the Study:
- To identify mutagenic chromium(III) complexes using the Salmonella reversion assay.
- To elucidate the redox kinetics and DNA interaction mechanisms of mutagenic chromium(III) species.
- To investigate the role of ligands in directing the biological activity of chromium(III) complexes.
Main Methods:
- Salmonella reversion assay for mutagenicity testing.
- Cyclic voltammetry to analyze redox kinetics.
- Plasmid relaxation assays to assess DNA interaction in vitro.
Main Results:
- Mutagenic chromium(III) complexes exhibited reversible redox behavior and positive shifts in the Cr(III)/Cr(II) couple, indicating electron-donating capacity.
- These mutagenic complexes induced supercoiled DNA relaxation in vitro, suggesting single-strand breaks.
- Nonmutagenic complexes showed irreversible redox kinetics, more negative potentials, and no DNA relaxation.
- Ligand properties were shown to influence the redox activity and DNA-damaging potential of chromium(III) complexes.
Conclusions:
- The mechanism of chromium(III)-induced mutagenesis likely involves oxygen radicals generated via a Fenton-like reaction.
- The electrochemical properties and DNA-relaxing ability of chromium(III) complexes are directly linked to their mutagenicity.
- Ligands play a critical role in modulating the redox behavior and biological activity of chromium(III) complexes.